EATG » EHVA July 2016 Newsletter now out

EHVA July 2016 Newsletter now out

EATG has been participating in the European HIV Vaccine Alliance as a consortium member responsible for communication and dissemination of progress, results and findings.

With 37 million people living with HIV worldwide, and over 2 million new infections diagnosed each year, an effective vaccine is regarded as the most potent public health strategy for addressing the pandemic.  Despite the many advances in the understanding, treatment and prevention of HIV made over the past 30 years, the development of broadly-effective HIV vaccine has remained unachievable.

The European HIV Alliance (EHVA) is a five year project funded by the European Union’s Horizon 2020 Research and Innovation Programme designed to foster the development of an effective vaccine. The EHVA encompasses 39 partners, each with the expertise to promote a comprehensive approach to the development of an effective HIV vaccine. The international alliance, which includes academic and industrial research partners from all over Europe, as well as sub-Saharan Africa and North America, will work to discover and progress novel vaccine candidates through the clinic.

The July 2016 Newsletter (first newsletter of the project) was published today, and it is available from this link: EHVA Newsletter July 2016

Share on FacebookTweet about this on TwitterShare on Google+Pin on PinterestShare on LinkedIn
News categories: Vaccines, Scientific research